• GT Gain Therapeutics SA

    TI
    active
    Check credit rating Timeline
    Check credit ratingCredit rating
    Register number: CH-501.3.020.963-0
    Sector: Research and development

    Age of the company

    8 years

    Turnover in CHF

    PremiumPremium

    Capital in CHF

    359'639

    Employees

    PremiumPremium

    Active brands

    0

    Reports for GT Gain Therapeutics SA

    *displayed reports are examples
    preview

    Credit rating information

    Evaluation of credit rating with traffic light as risk indicator and other helpful data about the company.
    Find out more
    preview

    Economic information

    Comprehensive information about the economic situation of a company.
    Find out more
    preview

    Payment behaviour

    Assessment of the payment behaviour based on past invoices.
    Find out more
    preview

    Payment collection information

    Overview of current and past debt enforcement proceedings.
    Find out more
    preview

    Shareholder Information

    Find out which national and international companies the stock corporation you are interested in also holds shares in.
    Find out more
    preview

    Company dossier as PDF

    Contact information, changes in the company, turnover and employee figures, management, ownership, shareholding structure and other company data.
    Retrieve company dossier

    About GT Gain Therapeutics SA

    • GT Gain Therapeutics SA has its legal headquarters in Lugano, is active and operates in the sector «Research and development».
    • There are 4 active persons registered in the management.
    • The company has last modified its commercial register entry on 14.08.2024. All previous commercial register entries are available under «Notifications».
    • The UID registered in the commercial register of TI is CHE-438.987.642.
    • There are 2 other active companies that have registered an identical address. These include: KeyBioscience SA, Lugano Wealth Partners SA.

    Commercial register information

    Source: SOGC

    Sector

    Research and development

    Purpose (Original language)

    La creazione, la scoperta, lo sviluppo, la produzione, la concessione di licenze e la commercializzazione di prodotti e tecnologie nel settore farmaceutico e/o biotecnologico, ed in particolare nell'ambito di nuove terapie per la cura di malattie genetiche, malattie rare e altre malattie. La società presterà inoltre servizi per lo sviluppo di tali prodotti e tecnologie, e potrà svolgere ogni relativa attività. La società può aprire succursali e filiali in Svizzera e all'estero e acquistare partecipazioni e/o costituire altre imprese in Svizzera e all'estero. La società può inoltre esercitare tutte le attività commerciali, finanziarie o di altro genere che siano in relazione con o atte a perseguire lo scopo sociale.

    Auditor

    Source: SOGC

    Current auditor (1)
    Name City Since Until
    Ernst & Young AG
    Lugano 03.03.2021

    Former auditor (1)
    Name City Since Until
    KPMG SA
    Lugano 15.02.2019 02.03.2021

    Other company names

    Source: SOGC

    Past and translated company names

    • GT Gain Therapeutics Ltd
    • GT Gain Therapeutics AG

    Branches (0)

    Ownership structure

    No information on the ownership structure is known to us.

    Holdings

    No information on holdings is known to us.

    Newest SOGC notifications: GT Gain Therapeutics SA

    The latest updates from the Swiss Official Gazette of Commerce (SOGC) are available in the original language of the source commercial register office only. View all notifications

    SOGC 240814/2024 - 14.08.2024
    Categories: Change in management

    Publication number: HR02-1006106588, Commercial Registry Office Ticino, (501)

    GT Gain Therapeutics SA, in Lugano, CHE-438.987.642, società anonima (Nr. FUSC 146 del 30.07.2024, Pubbl. 1006097216).

    Nuove persone iscritte o modifiche:
    Islam, Khalid, cittadino britannico, in Milano (IT), presidente, con firma individuale [finora: in Lugano].

    SOGC 240730/2024 - 30.07.2024
    Categories: Change in management

    Publication number: HR02-1006097216, Commercial Registry Office Ticino, (501)

    GT Gain Therapeutics SA, in Lugano, CHE-438.987.642, società anonima (Nr. FUSC 93 del 15.05.2023, Pubbl. 1005746512).

    Persone dimissionarie e firme cancellate:
    Alder, Matthias Stephan, da Ziefen, in Arlington (US), membro, con firma collettiva a due;
    Bellotto, Manolo, da Capriasca, in Castagnola (Lugano), direttore, con firma collettiva a due.

    Nuove persone iscritte o modifiche:
    Hasler, Hans Peter, da Madiswil, in Küssnacht am Rigi (Küssnacht (SZ)), membro, con firma individuale;
    Mack, Gene Charles, cittadino statunitense, in New Jersey (US), membro, con firma collettiva a due.

    SOGC 230515/2023 - 15.05.2023
    Categories: Change in management

    Publication number: HR02-1005746512, Commercial Registry Office Ticino, (501)

    GT Gain Therapeutics SA, in Lugano, CHE-438.987.642, società anonima (Nr. FUSC 253 del 29.12.2022, Pubbl. 1005641969).

    Persone dimissionarie e firme cancellate:
    Calabrese, Salvatore, cittadino italiano, in Milano (IT), membro, con firma collettiva a due.

    Hit list

    Here you will find a link from the management to a hit list of persons with the same name who are registered in the commercial register.

    Title
    Confirm